Table 1.
Antimicrobial Agents | MICs (mg/L) and Resistance Genes | |||
---|---|---|---|---|
K. pneumoniae HS 01 | K. pneumoniae HS 02 | |||
Amikacin | >128 | R | >128 | R |
Ceftazidime | >32 | R | >32 | R |
Cefepime | >128 | R | >128 | R |
Aztreonam | >128 | R | >128 | R |
Meropenem | 4 | R | >64 | R |
Imipenem | 0.5 | S | 64 | R |
Piperacillin–Tazobactam | >256 | R | >256 | R |
Cefoperazone–Sulbactam | >128 | R | >128 | R |
Ceftazidime–Avibactam | >64 | R | 4 | S |
Aztreonam–Avibactam | 4 | S | 2 | S |
Meropenem–Vaborbactam | 4 | S | 16 | R |
Imipenem–Relebactam | 0.25 | S | 1 | S |
Cefiderocol | 8 | I | 2 | S |
Levofloxacin | >16 | R | >16 | R |
Ciprofloxacin | >8 | R | >8 | R |
Tigecycline | 2 | S | 2 | S |
Polymyxin B | >16 | R | >16 | R |
NG-test Carba 5 | Negative | Positive | ||
β-lactams | blaCTX-M-65, blaLAP-2, blaSHV-12, blaTEM-1B, blaKPC-33 | blaCTX-M-65, blaLAP-2, blaSHV-12, blaTEM-1B, blaKPC-2 | ||
Quinolone | qnrS1 | qnrS1 | ||
Aminoglycoside | addA2 | addA2 | ||
Fosfomycin | fosA | fosA | ||
Phenicol | catA2 | catA2 | ||
Trimethoprim | dfrA14 | dfrA14 |
R, resistant; S, susceptible.